T. Rowe Price Associates
GRNA

T. Rowe Price Associates’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

T. Rowe Price Associates’s Portfolio GRNA Stock Details GRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-13,492
Closed -$6K – 2983
2023
Q1 		$6K Hold
13,492
– – ﹤0.01% 2896
2022
Q4 		$16K Buy
13,492
+2,516
+23% +$2.98K ﹤0.01% 2884
2022
Q3 		$26K Buy
+10,976
New +$26K ﹤0.01% 2901